These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17227230)

  • 1. NF-kappa B as a target for cancer therapy.
    Melisi D; Chiao PJ
    Expert Opin Ther Targets; 2007 Feb; 11(2):133-44. PubMed ID: 17227230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
    de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
    Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear transcription factor-kappaB as a target for cancer drug development.
    Garg A; Aggarwal BB
    Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the NF-κB pathway in cancer therapy.
    Erstad DJ; Cusack JC
    Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB as a potential molecular target for cancer therapy.
    Lee CH; Jeon YT; Kim SH; Song YS
    Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.
    Baud V; Karin M
    Nat Rev Drug Discov; 2009 Jan; 8(1):33-40. PubMed ID: 19116625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
    Zeligs KP; Neuman MK; Annunziata CM
    Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
    Ukaji T; Umezawa K
    Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
    Lopez-Guerra M; Colomer D
    Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappa B as a therapeutic target in autoimmune disease.
    O'Sullivan B; Thompson A; Thomas R
    Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting NF-kappaB for colorectal cancer.
    Sakamoto K; Maeda S
    Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?
    Stoffel A
    Expert Opin Ther Targets; 2005 Oct; 9(5):1045-61. PubMed ID: 16185157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB in the crosshairs: Rethinking an old riddle.
    Bennett J; Capece D; Begalli F; Verzella D; D'Andrea D; Tornatore L; Franzoso G
    Int J Biochem Cell Biol; 2018 Feb; 95():108-112. PubMed ID: 29277662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer.
    Eskandani R; Kazempour M; Farahzadi R; Sanaat Z; Eskandani M; Adibkia K; Vandghanooni S; Mokhtarzadeh A
    Biomed Pharmacother; 2022 Dec; 156():113932. PubMed ID: 36411621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using NF-κB as a molecular target for theranostics in radiation oncology research.
    Liu YC; Chiang IT; Hsu FT; Hwang JJ
    Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor NF-kappaB as drug target.
    Haefner B
    Prog Med Chem; 2005; 43():137-88. PubMed ID: 15850825
    [No Abstract]   [Full Text] [Related]  

  • 18. NF-κB signaling in cancer stem cells: a promising therapeutic target?
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
    Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB in cancer therapy.
    Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecularly-targeted Strategy and NF-κB in lymphoid malignancies.
    Horie R
    J Clin Exp Hematop; 2013; 53(3):185-95. PubMed ID: 24369220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.